Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human fibrinogen for congenital fibrinogen deficiency
CTR20221038Phase 3Terminated
- Sponsor
- Sinopharm Shanghai Plasma-derived Biotherapies
- Start
- Dec 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Fibrinogen human in fibrinogen deficiency, sponsored by Sinopharm Shanghai Plasma-derived Biotherapies. Started Dec 2022; status: terminated.
02
Drugs
Fibrinogen human
03
Conditions
fibrinogen deficiency
Beyond the preview
Go deeper on CTR20221038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221038.